Adequate liver function (bilirubin ≤ 2 mg/dl and transaminase level ≤ 3 times the upper normal limit, or < 5 times for patients with liver metastasis, serum alkaline phosphatase < 2.5 times the upper normal limit, or < 5 times if liver metastases were present or < 10 times if bone metastases were present). [clinicaltrials_resource:92890774bfb03518db8b11a6c367d952]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Adequate liver function (bilirubin ≤ 2 mg/dl and transaminase level ≤ 3 times the upper normal limit, or < 5 times for patients with liver metastasis, serum alkaline phosphatase < 2.5 times the upper normal limit, or < 5 times if liver metastases were present or < 10 times if bone metastases were present). [clinicaltrials_resource:92890774bfb03518db8b11a6c367d952]
Bio2RDF identifier
92890774bfb03518db8b11a6c367d952
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:92890774bfb03518db8b11a6c367d952
identifier
clinicaltrials_resource:92890774bfb03518db8b11a6c367d952
title
Adequate liver function (bilir ...... bone metastases were present).
@en
type
label
Adequate liver function (bilir ...... 90774bfb03518db8b11a6c367d952]
@en